Univercells Technologies by Donaldson, a global provider of bioprocessing technologies, has launched the scale-X nexo bioreactor, a miniaturized, fixed-bed bioreactor offering a 0.5 m² growth surface, designed for efficient cell culture process development across multiple modalities. Engineered for seamless scalability, the scale-X nexo bioreactor is designed to reduce process development timelines, helping to drive down costs for researchers and biopharma companies.   As the smallest member o...